FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,670,516 | $9,140,000 | 2.34% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $3,887,000 | 1.96% |
ADAMS STREET PARTNERS LLC | 2,947,809 | $7,340,000 | 1.91% |
Sio Capital Management, LLC | 260,448 | $649,000 | 0.24% |
Orbimed Advisors | 3,224,770 | $8,030,000 | 0.15% |
Artal Group S.A. | 750,000 | $1,868,000 | 0.10% |
TPG GP A, LLC | 2,551,794 | $6,354,000 | 0.10% |
Perceptive Advisors | 1,052,445 | $2,621,000 | 0.08% |
Rock Springs Capital Management LP | 809,854 | $2,017,000 | 0.06% |
FEDERATED HERMES, INC. | 3,124,100 | $7,779,000 | 0.02% |